郭远林教授解读 | 瑞舒伐他汀对动脉粥样硬化斑块微钙化的影响
3 mm)","url":"","cnt":0},{"name":"B. 微钙化与临床不稳定相关,而片状钙化则是斑块稳定的标志","url":"","cnt":0},{"name":"C. 瑞舒伐他汀治疗6个月后,显著降低斑块¹⁸F-NaF摄取量","url"
3 mm)","url":"","cnt":0},{"name":"B. 微钙化与临床不稳定相关,而片状钙化则是斑块稳定的标志","url":"","cnt":0},{"name":"C. 瑞舒伐他汀治疗6个月后,显著降低斑块¹⁸F-NaF摄取量","url"
2024年,随着全球肥胖症患病率的持续增加,以及肥胖在心肾代谢综合征(CKM)中的核心驱动作用愈发突显,肥胖与心血管疾病(CVD)的关联愈发紧密,